« previous next »
Pages: [1]

Author Topic: (Abst.) Evaluating the risk of macrovascular events and mortality among people w/MS in England  (Read 41 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Evaluating the risk of macrovascular events and mortality among people w/MS in England
« on: July 28, 2020, 02:17:47 pm »

A study involving 12,251 people with MS showed that the people with MS were more likely to have cardiovascular events than 72,572 people without MS.


From JAMA Neurology (May 4, 2020), "Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England":


https://bit.ly/3gaZjzL
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
43 Views 		Last post August 04, 2020, 02:40:18 pm
by agate
0 Replies
45 Views 		Last post January 12, 2021, 08:42:21 pm
by agate
0 Replies
33 Views 		Last post June 13, 2022, 09:38:18 pm
by agate
0 Replies
29 Views 		Last post June 28, 2022, 09:38:05 pm
by agate
0 Replies
14 Views 		Last post April 09, 2023, 03:52:20 pm
by agate